PT BIO FARMA (PERSERO) PT BIO FARMA (PERSERO)

CATATAN ATAS LAPORAN KEUANGAN NOTES TO FINANCIAL STATEMENTS

31 Desember 2016 dan 2015 December 31, 2016 and 2015
(Dinyatakan dalam Rupiah, kecuali dinyatakan lain) (Expressed in Rupiah, unless otherwise stated)

6. PERSEDIAAN (lanjutan) 7. INVENTORIES (continued)

Persediaan barang senilai Rp 176.077.094.546,5 dijadikan jaminan
yang bersifat fidusia atas fasilitas kredit yang diterima dari PT Bank
Rakyat Indonesia (Persero) Tbk berdasarkan Surat Persetujuan
Fasilitas Pembiayaan No. R.II.291-ADK/DKR-2/12/ 2016, tanggal 1
Desember 2016 untuk jangka waktu kredit sampai dengan 18
Desember 2017 (catatan 37.i).
Inventories amounting to Rp.176.077.094.546,5 have been
pledged as fiduciary collateral for credit facility obtained from PT
Bank Rakyat Indonesia (Persero) Tbk , based on Letter of
Approval of Financing (SPPFP) No.R.II.291-ADK/DKR-2/12/ 2016
dated december 1, 2016 for the extension of credit period until
December 18, 2017. (notes 37.i)

7. UANG MUKA 7. ADVANCES

31 Desember 2016 31 Desember 2015
December 31, 2016 December 31, 2015
Pembelian Lokal 2.205.788.311 17.309.454.864 Domestic Purchases
Pembelian Barang Impor 42.995.436.451 58.096.388.624 Purshases of Imported Goods
Impor Dalam Penyelesaian 7.471.766.551 2.293.407.746 Import in Progress
Uang Muka Kaca Mata 1.700.000 - Glasses
Jasa Produksi - 20.142.840.366 Bonuses
Uang Muka Monitoring 1.250.000.000 1.600.000.000 Monitoring
Uang Muka Diklat 90.500.000 - Training
Uang Muka Lainnya 37.100.000 2.911.151.562 Others
Jumlah 54.052.291.312 102.353.243.161 Total

Uang Muka pembelian lokal sebesar Rp2.205.788.311 terutama Advances for local purchase of Rp2.205.788.311 mainly from the
dari pembangunan istal kuda di Cisarua sebesar Rp834.000.000. construction of stables in Cisarua Rp834.000.000.
Uang muka pembelian barang impor terdiri dari : Advance for purshases of imported goods consist of :
31 Desember 2016 31 Desember 2015
December 31, 2016 December 31, 2015
Upstream Tetanus Toxoid Vaccine Upstream Tetanus Toxoid Vaccine
Production Equipment 24.046.311.900 - Production Equipment
Antibody to Poliovirus Type1-3 4.039.000.000 4.343.571.504 Antibody to Poliovirus Type1-3
Vaksin MENINGITIS ACYW 0,5 ML 4.010.527.763 - Vaksin MENINGITIS ACYW 0,5 ML
Fermentor 150 L (volume 207 L) Complete Fermentor 150 L (volume 207 L)
With Accessories 3.835.010.608 - Complete With Accessories
Heatmarker VVM2 2.080.865.701 - Heatmarker VVM2
CEDI+Tangki Feed dan Permeated RO 1.122.510.680 - CEDI+Tangki Feed & Permeated RO
Autoclave for Desinfection 849.693.000 Autoclave for Desinfection
Autoclave for Sterilization 808.058.043 Autoclave for Sterilization
Integrated Filling Line 3 Vial 35.897.084.165 Integrated Filling Line 3 Vial
Integrated Filling Line 4 (Vial Filling Line For Integrated Filling Line 4 (Vial Filling
PentaBio Liquid Product) - 10.789.883.720 Line For PentaBio Liquid Product)
Multitray CS 40 - 1.540.461.784 Multitray CS 40
Heatmaker for OPV - 1.468.759.444 Heatmaker for OPV
Fermentor 150 L - 1.431.810.640 Fermentor 150 L
Pembelian lainnya 2.203.458.756 2.624.817.366 Others
42.995.436.451 58.096.388.624

Uang Muka Impor dalam penyelesaian sebesar Rp7.471.766.551 Advances for import in progress amounting of Rp7.471.766.551
merupakan pembayaran biaya asuransi, biaya bongkar muat, represent payments in advance for insurance, unloading, and
biaya inklaring, dan pajak terkait proses penanganan barang impor inklaring expenses and taxes related to the process of handling the
dari pelabuhan dalam negeri ke lokasi Perusahaan. imported goods from the port to the Company's location.

8. PERPAJAKAN 8. TAXES
a. Pajak Dibayar Dimuka a. Prepaid Taxes
31 Desember 2016 31 Desember 2015
December 31, 2016 December 31, 2015
Pajak Pertambahan Nilai - Masukan 225.907.519.874 239.924.469.571 Value Added Tax (VAT) - Input
Pungutan/Potongan PPN - Keluaran WAPU - 2.771.329.518 Witholding VAT - Output
PPh Pasal 22 467.020.625 24.220.380 Income Tax - Article 22
Estimasi PPh Badan 72.442.448.878 - Income Tax - Article 29
Jumlah 298.816.989.377 242.720.019.469 Total
24
PT BIO FARMA (PERSERO) PT BIO FARMA (PERSERO)
CATATAN ATAS LAPORAN KEUANGAN NOTES TO FINANCIAL STATEMENTS
31 Desember 2016 dan 2015 December 31, 2016 and 2015
(Dinyatakan dalam Rupiah, kecuali dinyatakan lain) (Expressed in Rupiah, unless otherwise stated)

8. PERPAJAKAN (lanjutan) 8. TAXES (continued)

a. Pajak Dibayar Dimuka (lanjutan)
Saldo PPN Masukan per 31 Desember 2016 setelah
memperhitungkan restitusi PPN Masa Pajak Juli sampai
dengan Desember 2013 sebesar Rp41.919.562.727,00 sesuai
Surat Perintah Membayar Kelebihan Pajak (SPMKP) No.
80054/051-00054-2016 tanggal 4 Januari 2016; restitusi PPN
Masa Pajak Januari sampai dengan Juni 2014 sebesar
Rp40.195.806.361,00 sesuai Surat Perintah Membayar
Kelebihan Pajak (SPMKP) No.80055/051-00055-2016 tanggal
10 Pebruari 2016; restitusi PPN Masa Pajak September 2014
sebesar Rp17.784.958.518,00 sesuai Surat Perintah Membayar
Kelebihan Pajak (SPMKP) No. 00019/4071/14/051/2016
tanggal 21 Maret 2016 dan restitusi PPN Masa Pajak
Desember 2014 sebesar Rp24.891.987.705,00 sesuai Surat
Perintah Membayar Kelebihan Pajak (SPMKP)
No.80392/051-00392-2016 tanggal 13 September 2016.
a. Prepaid Taxes (continued)
The balance of input-Value Added Tax (VAT) as of December
31, 2016 has taken into account the amount of VAT refund for
the period of July to December 2013 amounted to
Rp41.919.562.727,00 , in accordance with Order Letter of
Payment of Tax Overpayment (SPMKP) No.80054/05-
00054-2016 dated January 4, 2016; VAT refund for the period
of January to June 2014 amounted to Rp40.195.806.361,00 ,
in accordance with Order Letter of Payment of Tax
Overpayment (SPMKP) No.80055/051-00055-2016 dated
February 10, 2016; VAT refund for the period of September
2014 amounted to Rp17.784.958.518,00 , in accordance with
Order Letter of Payment of Tax Overpayment (SPMKP)
No.800019/4071/14/051/2016 dated March 21, 2016; VAT
refund for the period of December 2014 amounted to
Rp24.891.987.705,00 , in accordance with Order Letter of
Payment of Tax Overpayment (SPMKP) No.80392/051-
00392-2016 dated September 13, 2016.

Saldo PPN Masukan per 31 Desember 2015 setelah
memperhitungkan restitusi PPN Masa Pajak Januari sampai
dengan Juni 2013 sebesar Rp28.875.864.464,00 sesuai Surat
Perintah Membayar Kelebihan Pajak (SPMKP) No.
80034/051-00034-2015 tanggal 27 Januari 2015.
The balance of input-Value Added Tax (VAT) as of December
31, 2015 has taken into account the amount of VAT refund for
the period of January to June 2013 amounted to
Rp28.875.864.464, in accordance with Order Letter of
Payment of Tax Overpayment (SPMKP) No.80034/051-00034-
2015 dated January 27, 2015.

b. Utang Pajak b. Taxes Payable

31 Desember 2016 31 Desember 2015
December 31, 2016 December 31, 2015
PPN Wapu 8.578.384.336 7.604.700.883 Witholding VAT - Output
Pajak Penghasilan Final Pasal 4 (2) 302.413.308 733.674.778 Income Tax - Final
Pajak Penghasilan Pasal 21 17.987.801.926 11.426.370.886 Income Tax Article 21
Pajak Penghasilan Pasal 22 407.189.034 1.169.311.152 Income Tax Article 22
Pajak Penghasilan Pasal 23 183.631.313 349.265.374 Income Tax Article 23
Pajak Penghasilan Pasal 25 20.164.941.321 17.228.940.681 Income Tax Article 25
Pajak Penghasilan Pasal 29 - 8.006.023.428 Income Tax Article 29
Jumlah 47.624.361.238 46.518.287.182 Total

c. Manfaat (Beban) Pajak Penghasilan c. Income Taxes Benefit (Expense)

31 Desember 2016
December 31, 2016
Pajak Kini (185.425.250.000)
Manfaat (Beban) Pajak Tangguhan 1.498.194.382
Beban Pajak Penghasilan - Bersih (183.927.055.618)
31 Desember 2015
December 31, 2015
(232.893.457.000)
4.212.772.294
(228.680.684.706)
Current tax
Deferred Tax Benefit (Expense)
Income Tax Expense - Net

d. Rekonsiliasi antara laba komersial dan laba fiskal : d. Reconciliation between commercial and taxable income :
31 Desember 2016 31 Desember 2015
December 31, 2016 December 31, 2015
Laba sebelum pajak penghasilan Income before income tax
menurut laporan laba rugi 684.968.045.701 899.273.575.951 as shown in statement of profit or loss
Beda Waktu Temporary Differences
Beban imbalan pasca kerja 6.797.917.415 14.825.592.378 Employees benefit expense
Penyisihan penurunan nilai piutang 33.389.016 190.140.350 Provision for impairment of receivables
Penyisihan nilai persediaan (838.528.904) 1.835.356.447 Provision for impairment of inventories
Pemulihan biaya dibayar dimuka - 4.767.416.002 Recovery of prepaid expenses
Jumlah Beda Waktu 5.992.777.527 21.618.505.177 Total Temporary Differences

25
PT BIO FARMA (PERSERO) PT BIO FARMA (PERSERO)
CATATAN ATAS LAPORAN KEUANGAN NOTES TO FINANCIAL STATEMENTS
31 Desember 2016 dan 2015 December 31, 2016 and 2015
(Dinyatakan dalam Rupiah, kecuali dinyatakan lain) (Expressed in Rupiah, unless otherwise stated)

8. PERPAJAKAN (lanjutan) 8. TAXES (continued)

d. Rekonsiliasi antara laba komersial dan laba fiskal : d. Reconciliation between commercial and taxable income :
31 Desember 2016 31 Desember 2015
December 31, 2016 December 31, 2015
Beda Permanen Permanent Different
Tantiem 13.275.000.000 16.540.204.371 Management bonus
Beban Pajak Lainnya - 24.333.750 Other tax expenses
Koreksi pajak dan denda pajak 10.924.295.638 352.238.893 Tax and tax penalty corrections
Penghargaan dalam bentuk barang 1.112.146.820 341.701.090 Rewards in goods
Sumbangan sosial masyarakat 13.358.249.158 4.497.462.006 Public social donations
Bantuan sosial karyawan, Social aids for employee,
direksi dan komisaris 10.530.780.335 13.869.376.472 directors and commissioners
Beban HUT Perusahaan, The Company's anniversary,
olah raga dan paket ramadhan 4.166.338.898 3.880.861.129 sports and ramadhan packages
Penyusutan mobil direksi (50%) - 84.590.964 Depreciation of Driector's Cars (50%)
Tunjangan Komunikasi Direksi (50%) 58.684.399 80.877.904 Director's Communication Allowance
Beban Jamuan Tamu Perusahaan 3.691.586.542 4.884.585.811 Entertainment
Langganan perpustakaan dan Subscription of
surat kabar 85.896.000 131.912.199 newspapers and library
Beban promosi yang Non-deductible
tidak dapat dibiayakan 401.303.977 2.861.087.000 promotions
Bunga jasa giro dan deposito yang Interests of bank deposits accounts
dikenakan PPh Final (6.820.215.334) (36.901.605.304) subject to final tax
Penyusutan Mobil Non Direksi 177.486.328 277.458.863 Depreciation of Cars
Sewa ruangan dan bagi hasil yang Room rent and profit sharing
dikenakan PPh Final (221.375.000) (243.337.500) subject to final tax
Jumlah Beda Permanen 50.740.177.761 10.681.747.647 Total Permanent Differences
Laba Kena Pajak 741.701.000.989 931.573.828.776 Taxable Income
Laba Kena Pajak (Dibulatkan) 741.701.000.000 931.573.828.000 Taxable Income (rounded-off)

Taksiran Beban Pajak Penghasilan Estimated Income Tax Expense

25% x 741.701.000.000 185.425.250.000 25% x 741.701.000.000
25% x 931.573.828.000 232.893.457.000 25% x 931.573.828.000
Dikurangi : Pajak Dibayar Dimuka Less : Prepaid Taxes
Pasal 22 15.825.799.593 18.079.362.507 Article 22
Pasal 23 62.603.433 60.782.894 Article 23
Pasal 25 241.979.295.852 206.747.288.172 Article 25
257.867.698.878 224.887.433.573
(Lebih) Kurang Bayar PPh Badan (72.442.448.878) 8.006.023.428 Income Tax (Over) Under Payment

e. Pajak Tangguhan e. Deferred Tax

Rekonsiliasi antara taksiran pajak penghasilan yang dihitung The reconciliation between estimated income tax expense
dengan menggunakan tarif pajak yang berlaku sebesar 25% computed using the prevailing tax rate of 25% of the income
dari laba akuntansi sebelum taksiran beban (manfaat) pajak before income tax expense (benefit) and the tax expense as
penghasilan dan beban pajak seperti yang tercantum dalam shown in the statement of profit or loss dan other
laporan laba rugi dan penghasilan komprehensif lain tanggal 31 comprehensive income for the years ended December 31,
Desember 2016 dan 2015 : 2016 and 2015 are as follows :
31 Desember 2016 31 Desember 2015
December 31, 2016 December 31, 2015
Laba sebelum pajak penghasilan 684.968.045.701 899.273.575.951 Income before income tax
Beban Pajak dengan Tax Expense based on
Tarif Pajak Maksimum 171.242.011.425 224.818.393.988 Maximum Rate
Pengaruh Pajak atas Tax Impact on
Beda Permanen 12.685.044.193 2.670.436.718 Permanent Differences
Pemulihan Biaya Dibayar Dimuka - 1.191.854.000 Prepaid Expense Recovery
Beban Pajak Perusahaan 183.927.055.618 228.680.684.706 Corporate Tax Expense
Beban Kini 185.425.250.000 232.893.457.000 Current Tax
Beban (Manfaat) Pajak Tangguhan (1.498.194.382) (4.212.772.294) Deferred Tax Expense (Asset)

26
PT BIO FARMA (PERSERO) PT BIO FARMA (PERSERO)
CATATAN ATAS LAPORAN KEUANGAN NOTES TO FINANCIAL STATEMENTS
31 Desember 2016 dan 2015 December 31, 2016 and 2015
(Dinyatakan dalam Rupiah, kecuali dinyatakan lain) (Expressed in Rupiah, unless otherwise stated)

8. PERPAJAKAN (lanjutan) 8. TAXES (continued)

e. Pajak Tangguhan e. Deferred Tax
Pajak tangguhan dihitung berdasarkan pengaruh dari Deferred tax is computed based on the effect of the temporary
perbedaan temporer antara jumlah tercatat aset dan Iiabilitas differences between the carrying amounts of assets and liabilities
menurut laporan keuangan dari dasar pengenaan pajak aset of their respective tax bases.
dan Iiabilitas.
Rincian aset dan liabilitas pajak tangguhan Perusahaan adalah Details of the Company's deferred tax assets and liabilities are as
sebagai berikut: follows:
Dibebankan ke Dibebankan ke
Laba Rugi Laba Rugi
2014 Komprehensif/ 2015 Komprehensif/ 2016
Charged to Charged to
Profit or Loss Profit or Loss

Aset Pajak Tangguhan Deferred Tas Asset

Imbalan Kerja 16.503.697.460 3.706.398.095 20.210.095.554 1.699.479.354 21.909.574.908 Employee Benefit
Penyisihan Piutang Ragu-ragu 356.279.783 47.535.088 403.814.871 8.347.254 412.162.125 Impairment of Receivables
Penyisihan Persediaan 1.014.078.978 458.839.112 1.472.918.089 (209.632.226) 1.263.285.863 Impairment of Inventories
Jumlah Aset Pajak Tangguhan 17.874.056.221 4.212.772.294 22.086.828.515 1.498.194.382 23.585.022.896 Total Deferred Tax Asset

9. BIAYA DIBAYAR DIMUKA 9. PREPAID EXPENSES

31 Desember 2016 31 Desember 2015
December 31, 2016 December 31, 2015
Asuransi 3.120.461.278 2.744.307.875 Insurances
Sewa 9.016.048.583 7.418.819.000 Rents
Jumlah 12.136.509.861 10.163.126.875 Total

Asuransi dibayar dimuka terdiri dari : Prepaid insurance consist of :

Asuransi karyawan 156.937.288 344.558.500 Employee insurance
Asuransi persediaan 175.199.558 72.963.510 Inventories insurance
Asuransi kebakaran bangunan dan Fire of buildings and
aset tetap didalamnya 2.780.127.930 2.286.636.948 related fixed assets
Asuransi kendaraan 8.196.503 40.148.917 Vehicle insurance
3.120.461.278 2.744.307.875

Asuransi dibayar di muka tersebut merupakan saldo premi
asuransi yang diterbitkan oleh PT Asuransi Jiwasraya (Persero),
BNI Life, PT Asuransi Parolamas, PT Asuransi Bumiputera Muda
1967, PT Mandiri AXA General Insurance, PT Asuransi Jasa
Tania, PT Asuransi Kredit Indonesia dan PT Asuransi Jasa
Indonesia (Persero).
Saldo Sewa dibayar dimuka per 31 Desember 2016 sebesar
Rp9.016.048.583,25 terutama berasal dari bagian lancar sewa
dibayar dimuka yang jatuh tempo di tahun 2017 atas lahan Barang
Milik Negara (BMN) aset eks BPPN di Jasinga Bogor sebesar
Rp20.821.344.000 dengan jangka waktu sewa selama 3 tahun.
Perusahaan menggunakan tanah yang saat ini masih dalam
proses PMN tersebut sebagai persiapan rencana pengembangan
bisnis perusahaan ke arah life science. Saat ini dilakukan kegiatan
CSR sebagai jaring pengaman sosial seperti access to medicine
dan pengolahan air bersih, sehingga masyarakat dan pemerintah
daerah setempat dapat menerima keberadaan PT Bio Farma
(Persero). (lihat catatan 14)
These prepaid insurances represent insurance premiums paid in
advance to PT Asuransi Jiwasraya (Persero), BNI Life, PT
Asuransi Parolamas, PT Asuransi Bumiputera Muda 1967, PT
Mandiri AXA General Insurance, PT Asuransi Jasa Tania, PT
Asuransi Kredit Indonesia dan PT Asuransi Jasa Indonesia
(Persero).
The balance of prepaid rent as of December 31,2016 amounting to
Rp9.016.048.583,25 particularly deals with rental cost of
Government-owned land (BMN) ex. BPPN at Jasinga Bogor. The
rental cost is of Rp20.821.344.000 for three years. The Company
uses the land, which is in the process to be the Goverment
investment in the Company, to prepare its business development
plan toward life science. Currently, at this location the Company
performs CSR activities as social safety net such as access to
medicine and processing clean water, with the result that the local
Government and its society accept the existence of the Company.
(see notes 14).

27